At the Hutchinson Center, safety is our highest priority and we do everything we can to protect clinicals trials participants against unnecessary risks. At the same time, all clinical studies contain a degree of risk. We minimize that by following rigorous safety procedures and practices.
All of our clinical trials follow strict federal guidelines governing how clinical trials participants must be treated. And, before any clinical trial can begin, it must receive approval from our internal Institutional Review Board (IRB). One of the IRB's core responsibilities is to represent and protect the interests of clinical trials participants. The IRB evaluates the scientific and ethical issues surrounding new trials, carefully weighs the trials' risks and potential benefits, and ensures that controls are in place to protect patient safety and privacy.